Pramana, Inc.

Pramana, Inc. is a US-based company specializing in automation for pathology labs, focusing on advanced digital pathology solutions to enhance imaging efficiency and accuracy across various medical specimens. Founded in 2021 and headquartered in Cambridge, US, Pramana, Inc. automates digital pathology through innovative imaging technologies.

The company has completed one investment deal, with its most recent being in August 2025, where Evident Corporation acquired an undisclosed stake. The founder's specific history is not detailed in available information. Pramana specializes in digital pathology solutions, focusing on autonomous whole slide imaging systems designed to enhance the efficiency and accuracy of pathology laboratories. Their core product offerings include modular scanner systems that effectively manage slide loading, label handling, and artifact management.

These systems utilize advanced volumetric imaging techniques that replicate the fine-focus function of optical microscopes, yielding high-quality whole slide images across various specimen types, including tissue, cytology, and microbiology samples. The company’s products are tailored for laboratories in the United States and Canada, catering primarily to anatomic pathology, cytopathology, hematopathology, and clinical pathology sectors. By offering customizable setups that allow users to select configurations based on their specific workflow needs, Pramana aims to optimize laboratory processes and improve diagnostic outcomes. Pramana operates on a business model that primarily involves B2B transactions with healthcare organizations and laboratories.

Revenue is generated through the sale of their scanning systems, which may come with additional modular upgrades and accessory kits to enhance functionality. These products often involve a direct sales approach, where clients can customize their scanner configurations according to their operational demands. The company’s revenue stream is supported by partnerships with leading healthcare organizations and may include service agreements for ongoing technical support. Pricing structures are aligned with the complexity and capabilities of the scanner systems, with options for additional features and upgrades that clients can select based on their individual needs.

In August 2025, Evident Corporation, a portfolio company of Bain Capital, acquired an undisclosed stake in Pramana, Inc. The acquisition aims to integrate autonomous imaging with optical microscopy, expand digital pathology solutions, and accelerate intelligent diagnostics across healthcare and research institutions. Pramana plans to leverage this acquisition to enhance its product offerings and potentially introduce new products in the near future, while also targeting expansion into new markets, particularly in North America.